Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease collagen disease
Phenotype C0041296|tuberculosis
Sentences 6
PubMedID- 21161670 To compare the value of a t-cell-based enzyme-linked immunospot assay (elispot) t-spot.tb and conventional (tst) in screening and monitoring tuberculosis in patients with rheumatic diseases during infliximab therapy in china.
PubMedID- 24788999 Objective: to review the official international recommendations on the management of latent tuberculosis infection (ltbi) in patients with rheumatic diseases undergoing biologic therapy.
PubMedID- 22815006 Owing to the relative rareness of overt tuberculosis in patients with rheumatic diseases, the experience of individual rheumatologists with this complication is limited.
PubMedID- 21822042 This article gives the recommendations for the prevention and management of tuberculosis in patients with rheumatic diseases before initiating therapy with tumor necrosis factor alpha inhibitors.
PubMedID- 20040648 Recommended screening strategy for preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in india - followup report.
PubMedID- 25376466 The aim of this study is to assess the diagnostic value of interferon-gamma release assays (igras) for latent tuberculosis infection (ltbi) in patients with rheumatic disease before receiving biologic agents.

Page: 1